RemedyRepack Recalls Lorazepam Injections Due to Incorrect Storage Instructions
RemedyRepack Inc. is recalling 1,625 vials of Lorazepam 2 mg/mL injection because the product labels contain incorrect storage instructions.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II and involves a labeling error (incorrect storage instructions) without reported injuries or illnesses, fitting the criteria for a moderate severity voluntary precautionary recall.
Plain-English summary
RemedyRepack Inc. is voluntarily recalling 1,625 vials of Lorazepam 2 mg/mL Injection. The product was originally manufactured by West-Ward Pharma and repackaged by RemedyRepack Inc. The recall is being conducted because the product labels contain incorrect storage instructions.
The affected product is identified by NDC 61786-0316-01. Specific lot numbers and expiration dates are listed in the recall documentation. The products were distributed nationwide.
Consumers and healthcare providers should check their inventory for the specific lot numbers and expiration dates listed in the official recall notice. If the product is found, it should be returned to the supplier or disposed of according to local regulations. No specific health risks or adverse events are reported in the source text.
The recalled product
- Product
- Lorazepam 2 mg/mL Inj., Qty: 1 mL Vial, MFG by: West-Ward Pharma, Eatontown, NJ 07724, Repackaged by: RemedyRepack Inc., 625 Kolter Dr., Indiana, PA 15701, NDC 61786-0316-01
- Manufacturer
- RemedyRepack Inc.
- Category
- Drug — Injectable Medication
- Hazard
- Affected units
- 1,625
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- LOT#: B0085124-051915
- B0086919-052815
- Exp 12/01/2016
- B0089280-061215
- B0090023-061915
- B0089996-061915
- B0091581-070715
- B0091564-070715
- B0091515-070715
- Exp 01/01/2017
- B0094980-080415
- B0094965-080415
- B0097515-082415
- B0100639-091415
- B0100611-091415
- Exp 03/01/2017
- B0100933-091515
- B0107165-101915
- B0107118-101915
- Exp 06/01/2017.
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 7 recalled by RemedyRepack Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 7 products in this recall →Related recalls
Same manufacturer · RemedyRepack Inc.
See all →- ModerateClindamycin HCl Capsule 300 mg repackaged by RemedyRePack Inc.
FDA (Drugs) · 2025-05-14
- ModerateClindamycin HCl 300 mg Capsule Recalled for CGMP Deviations
FDA (Drugs) · 2025-04-30
- HighCarvedilol 25 mg tablets recalled due to N-nitroso impurity above limit
FDA (Drugs) · 2025-02-12
- HighDuloxetine delayed-release capsules recalled due to manufacturing impurity
FDA (Drugs) · 2025-01-01
- HighPotassium Chloride Extended Release Capsules Recalled for Dissolution Defect
FDA (Drugs) · 2024-07-24
Same hazard · mis labeling
See all →- ModerateMedline Trach Tube Kit Recalled for Component Labeling Discrepancy
FDA (Devices) · 2026-09-02
- ModerateAVID Medical Recalls Halyard Total Joint Kits for Latex Labeling Deficiency
FDA (Devices) · 2026-09-02
- ModerateOlympus Recalls PowerSeal Sealer Due to Incorrect Outer Box Labeling
FDA (Devices) · 2026-09-02
- HighSura Tanmen Ramen Noodles Recalled for Undeclared Fish Allergens
FDA (Food) · 2026-09-02
- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-09-02